Air Pollution Linked to Worse Outcomes for COVID-19 Patients

MONDAY, June 26, 2023 (HealthDay News) -- For patients with COVID-19, exposure to air pollution is associated with increased duration of hospitalization and with increased risk of adverse outcomes, according to two studies published online June 21 in the European Respiratory Journal.
Stijn Vos, from Hasselt University in Belgium, and colleagues recruited 328 hospitalized COVID-19 patients from two hospitals and modeled daily exposure levels for particulate matter (PM2.5 and PM10), nitrogen dioxide (NO2), and black carbon using a high-resolution spatiotemporal model. The researchers found that an interquartile range increase in exposure in the week before admission was associated with increased duration of hospitalization (PM2.5: +4.22 days; NO2: +4.33 days). Similar effects on hospitalization duration were seen for long-term NO2 and black carbon exposure.
Jiawei Zhang, from the University of Copenhagen in Denmark, and colleagues followed 3,721,810 Danish residents 30 years and older in the National COVID-19 Surveillance System. The associations of air pollutants with COVID-19 outcomes were estimated. The researchers found that during 14 months, 138,742 individuals were infected, 11,270 were hospitalized, and 2,557 died from COVID-19. PM2.5 (per 0.5 µg/m-3) and NO2 (per 3.6 µg/m-3) were associated with COVID-19 incidence (hazard ratios, 1.10 and 1.18, respectively), hospitalizations (hazard ratios, 1.09 and 1.19, respectively), and death (hazard ratios, 1.23 and 1.18, respectively). The associations were strongest in the lowest socioeconomic groups and for those with chronic respiratory, cardiometabolic, and neurodegenerative disease.
"This article reinforces the evidence that community intervention on air pollution abatement would be a very effective way to protect our population from the impact of COVID-19, with the co-benefit of the protection against other respiratory infections as well," write the authors of an accompanying editorial.
Several authors from the second study reported ties to the pharmaceutical industry.
Related Posts
Two Cases of New Drug-Resistant Gonorrhea Strain Reported in Massachusetts
FRIDAY, Jan. 20, 2023 (HealthDay News) -- Two cases of a new strain of gonorrhea...
Vacuum-Induced Control Device Beneficial for Postpartum Hemorrhage
TUESDAY, Sept. 26, 2023 (HealthDay News) -- Rapid and effective bleeding control...
Stay Fit to Avoid A-Fib and Stroke
TUESDAY, Aug. 22, 2023 (HealthDay News) -- People can help reduce their odds of...
White House Urges COVID-19 Booster Shots Again, Citing Effectiveness
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Whether it is the bivalent vaccine...